In order to investigate the efficacy and safety of the AAV micro-dystrophin therapies to treat DMD, three clinical trials started recently in USA (i.e., NCT03368742, NCT03375164, and NCT03362502, see Table 1) [97]. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.